Literature DB >> 16938735

Tick-borne encephalitis (TBE) in Skåne, southern Sweden: A new TBE endemic region?

Fält Johan1, Lundgren Asa, Alsterlund Rolf, Carlsson Barbro, Eliasson Ingvar, Haglund Mats, Lundkvist Ake, Vene Sirkka, Settergren Bo.   

Abstract

No case of tick-borne encephalitis (TBE) has previously, to our knowledge, been reported from the region of north-eastern Skåne in southern Sweden. However, since the y 2001 we have identified 6 cases of TBE in this region occurring in a limited geographical area covering about 100 km2. Sera from 393 patients living in the vicinity of those TBE cases were analysed for the presence of TBE virus-specific IgG by use of ELISA. TBE virus IgG titres >126 VIEU (Vienna Units) were detected in 28 (7.1%) of the patients' sera. However, in only 3 of the ELISA TBE virus IgG positive sera were neutralizing antibodies against TBE virus demonstrated. Those 3 sera all had IgG titres of >380 VIEU. The TBE seroprevalence rate in this non-randomized population sample in north-eastern Skåne was calculated at 0.8%.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16938735     DOI: 10.1080/00365540600664068

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  3 in total

Review 1.  Why is tick-borne encephalitis increasing? A review of the key factors causing the increasing incidence of human TBE in Sweden.

Authors:  Thomas G T Jaenson; Marika Hjertqvist; Tomas Bergström; Ake Lundkvist
Journal:  Parasit Vectors       Date:  2012-08-31       Impact factor: 3.876

2.  Increased Relative Risk of Tick-Borne Encephalitis in Warmer Weather.

Authors:  Milan Daniel; Vlasta Danielová; Alena Fialová; Marek Malý; Bohumír Kříž; Patricia A Nuttall
Journal:  Front Cell Infect Microbiol       Date:  2018-03-22       Impact factor: 5.293

3.  Climate change influences infectious diseases both in the Arctic and the tropics: joining the dots.

Authors:  Birgitta Evengård; Rainer Sauerborn
Journal:  Glob Health Action       Date:  2009-11-11       Impact factor: 2.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.